HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference21 articles.
1. New era of liver transplantation for hepatitis B: a 17-year single-center experience;Anselmo;Ann Surg,2002
2. Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis;Rao;Transpl Int,2009
3. Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?;Zoulim;J Hepatol,2003
4. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation;Fontana;Liver Transpl,2001
5. Decreasing viral load pretransplant and passive immunoprophylaxis with hepatitis B immunoglobulin posttransplant prevents hepatitis B virus recurrence after liver transplantation: an 8-year single-center experience;Tchervenkov;Transplant Proc,2001
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta‐analysis;European Journal of Clinical Investigation;2021-05-03
2. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma;Cancer Letters;2016-09
3. YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy;Hepatitis Monthly;2015-07-22
4. Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience;Transplantation Proceedings;2015-06
5. Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin;Transplant Infectious Disease;2015-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3